Novel therapeutics in myeloproliferative neoplasms

Hyperactive signaling of the Janus-Associated Kinase/Signal Transducers and Activators of Transcription (JAK/STAT) pathway is central to the pathogenesis of Philadelphia-chromosome-negative myeloproliferative ...

Source: Journal of Hematology and Oncology - December 2, 2020 Category: Hematology Authors: Sangeetha Venugopal and John Mascarenhas Tags: Review Source Type: research